Discover 1 curated intelligence briefings related to this specific topic.
Biotech is moving beyond traditional transplants. With 1.5 billion dollars flowing into AI-driven target discovery and the rise of Lgr5 stem cell organoids, the race to synthesize functional liver tissue has reached a critical velocity.
